Compare · KRMD vs MDLN
KRMD vs MDLN
Side-by-side comparison of KORU Medical Systems Inc. (KRMD) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both KRMD and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $44.40B, about 242.3x KRMD ($183.3M).
- Over the past year, KRMD is up 31.8% and MDLN is down 13.4% - KRMD leads by 45.2 points.
- MDLN has been more active in the news (20 items in the past 4 weeks vs 10 for KRMD).
- MDLN has more recent analyst coverage (25 ratings vs 6 for KRMD).
- Company
- KORU Medical Systems Inc.
- Medline Inc.
- Price
- $4.00+0.88%
- $35.13+3.97%
- Market cap
- $183.3M
- $44.40B
- 1M return
- -10.51%
- -10.66%
- 1Y return
- +31.80%
- -13.45%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 10
- 20
- Recent ratings
- 6
- 25
KORU Medical Systems Inc.
Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
Latest KRMD
- KORU Medical Systems Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Chief Technology Officer Schiller Eric bought $19,562 worth of shares (5,000 units at $3.91) (SEC Form 4)
- Amendment: Chief Executive Officer Tharby Linda M bought $4,669 worth of shares (1,191 units at $3.92), increasing direct ownership by 0.19% to 620,622 units (SEC Form 4)
- Chief Executive Officer Tharby Linda M bought $1,418,481 worth of shares (1,191 units at $1,191.00), increasing direct ownership by 0.19% to 620,622 units (SEC Form 4)
- Chief Executive Officer Tharby Linda M converted options into 13,977 shares and covered exercise/tax liability with 7,326 shares, increasing direct ownership by 1% to 619,431 units (SEC Form 4) (for withholding tax)
- Chief Operating Officer Pazdan Christopher converted options into 5,327 shares and covered exercise/tax liability with 1,470 shares, increasing direct ownership by 1% to 308,988 units (SEC Form 4) to cover withholding tax
- Chief Operating Officer Pazdan Christopher bought $19,400 worth of shares (5,000 units at $3.88), increasing direct ownership by 2% to 305,131 units (SEC Form 4)
- Chief Financial Officer Adams Thomas Edward converted options into 8,193 shares and covered exercise/tax liability with 2,900 shares, increasing direct ownership by 2% to 313,440 units (SEC Form 4) to cover taxes
- Chief Financial Officer Adams Thomas Edward bought $21,248 worth of shares (5,500 units at $3.86), increasing direct ownership by 2% to 308,147 units (SEC Form 4)
- KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)